Showing results (31-40 of 76) with videos related to
Sort By:
Pageof 8
Dermatology Reports|October 4, 2023
Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative studyAndrea Cortese, Luigi Gargiulo, Luciano Ibba, et al.Rheumatology (Oxford, England)|June 21, 2021
Real-life efficacy of guselkumab in patients with early psoriatic arthritisIlenia Pantano, Daniele Mauro, Francesca Romano, et al.Journal of Drugs in Dermatology : JDD|August 2, 2024
Real-life Effectiveness and Safety of Guselkumab in Moderate-to-Severe Plaque Psoriasis: A 104-Week Retrospective Single-Center StudyLuigi Gargiulo, Luciano Ibba, Andrea Cortese, et al.Melanoma Research|November 8, 2023
Bone marrow metastases: a systematic review of a neglected involvement in malignant melanomaGiovanni Paolino, Andrea Carugno, Franco Rongioletti, et al.International Journal of Dermatology|March 5, 2021
Impact of delay in follow-up due to COVID-19 pandemic on skin cancer progression: a real-life experience from an Italian hub hospitalMario Valenti, Giulia Pavia, Luigi Gargiulo, et al.Cancers|November 13, 2025
From Diagnosis to Therapy in Primary Cutaneous Extramammary Paget's Disease: A Systematic Review of Non-Invasive and Non-Surgical ApproachesFrancesco D'Oria, Francesco Piscazzi, Matteo Liberi, et al.Journal of Clinical Medicine|February 13, 2025
Age-Related Variations in Clinical, Histological, and Genetic Characteristics in Multiple and Familial Melanomas: A Study of 333 PatientsAndrea Carugno, Giovanni Paolino, Mario Valenti, et al.Diagnostics (Basel, Switzerland)|April 14, 2026
Unveiling the Importance of Early Detection of Oral Mucosal Melanoma with Non-Invasive Imaging TechniquesBeatrice Bălăceanu-Gurău, Matteo Liberi, Francesco D'Oria, et al.Dermatology and Therapy|September 5, 2022
Real-Life Effectiveness and Safety of Risankizumab in 131 Patients Affected by Moderate-to-Severe Plaque Psoriasis: A 52-Week Retrospective StudyLuigi Gargiulo, Luciano Ibba, Giulia Pavia, et al.Journal of Cosmetic Dermatology|January 3, 2026
Pro-Inflammatory Signaling in Dermal Fibroblasts: A Possible Role of Different Botulinum Toxin Formulations on IL-6 ExpressionSabrina Sommatis, Roberto Mocchi, Serena Di Francesco, et al.Pageof 8